Definium Therapeutics stockDFTX
Definium Therapeutics trades at $30.36, 38.9% below its 52-week high (Aug 7, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +126.7% year to date, +163.3% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 9, 2026.
Ratings, candles, signals and the screener for DFTX — after you log in
Open the terminalFrequently asked questions about Definium Therapeutics
What is the Definium Therapeutics stock price?
At the close on Nov 5, 2026: $30.36 (−7.16% on the day). 52-week high: $49.70 on Aug 7, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Definium Therapeutics report earnings?
The next quarterly report is on Nov 9, 2026. Last quarter, earnings per share changed −188% year over year, revenue 0%.
Does Definium Therapeutics pay dividends?
No, Definium Therapeutics does not pay dividends.
Where does Definium Therapeutics trade and how to buy it?
Ticker DFTX, exchange Nasdaq. You can buy it through a broker with access to US exchanges.
Should I buy Definium Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for DFTX are in the terminal after you log in.